Dextran 75 (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Dextran 75 drug offered from AnazaoHealth Corporation. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Dextran 75
SUBSTANCE NAME: DEXTRAN 75
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00


Dextran 75 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDextran 75 from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-210_29c1fd45-7d77-4882-9e73-8a66742be742
PRODUCT NDC: 51808-210
APPLICATION NUMBER:

Other DEXTRAN 75 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationDextran 75